Cargando…

Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most lethal malignant tumours worldwide. The mortality-to-incidence ratio is up to 91.6% in many countries, representing the third leading cause of cancer-related deaths. Systemic drugs, including the multikinase inhibitors sorafenib and lenvatinib, are f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villarruel-Melquiades, Fernanda, Mendoza-Garrido, María Eugenia, García-Cuellar, Claudia M, Sánchez-Pérez, Yesennia, Pérez-Carreón, Julio Isael, Camacho, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198058/ https://www.ncbi.nlm.nih.gov/pubmed/37213397 http://dx.doi.org/10.3748/wjg.v29.i17.2571

Ejemplares similares

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
por: Chávez-López, María de Guadalupe, et al.
Publicado: (2016)

Ion Channels as Potential Tools for the Diagnosis, Prognosis, and Treatment of HPV-Associated Cancers
por: Chiliquinga, Andrea Jazmín, et al.
Publicado: (2023)

Nucleotide Excision Repair Pathway Activity Is Inhibited by Airborne Particulate Matter (PM(10)) through XPA Deregulation in Lung Epithelial Cells
por: Quezada-Maldonado, Ericka Marel, et al.
Publicado: (2022)

PM(10 )from Mexico City (MC) induce senescence-like phenotype and ATM, γH2A.X and p53 activation linked to oxidative stress
por: Sánchez-Pérez, Yesennia, et al.
Publicado: (2007)

Sampling and composition of airborne particulate matter (PM(10)) from two locations of Mexico City
por: Chirino, Yolanda I., et al.
Publicado: (2015)

Deciphering the Code between Air Pollution and Disease: The Effect of Particulate Matter on Cancer Hallmarks
por: Santibáñez-Andrade, Miguel, et al.
Publicado: (2019)

Persistent activation of NF-kappaB related to IkappaB's degradation profiles during early chemical hepatocarcinogenesis
por: García-Román, Rebeca, et al.
Publicado: (2007)

Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine
por: Cerrato-Izaguirre, Dennis, et al.
Publicado: (2021)

The Road to Malignant Cell Transformation after Particulate Matter Exposure: From Oxidative Stress to Genotoxicity
por: Santibáñez-Andrade, Miguel, et al.
Publicado: (2023)

Airborne Particulate Matter (PM(10)) Inhibits Apoptosis through PI3K/AKT/FoxO3a Pathway in Lung Epithelial Cells: The Role of a Second Oxidant Stimulus
por: García-Cuellar, Claudia M., et al.
Publicado: (2020)

Particulate Matter (PM(10)) Promotes Cell Invasion through Epithelial–Mesenchymal Transition (EMT) by TGF-β Activation in A549 Lung Cells
por: García-Cuellar, Claudia M., et al.
Publicado: (2021)

Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis
por: Herrera-López, Ema Elvira, et al.
Publicado: (2023)

Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies
por: Idelfonso-García, Osiris Germán, et al.
Publicado: (2022)

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
por: Gonzalez-Sanchez, Ester, et al.
Publicado: (2021)

Hepatocellular carcinoma therapy finds a channel on the radio
por: Camacho, Javier
Publicado: (2019)

Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells
por: Acuña-Macías, Isabel, et al.
Publicado: (2015)

Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
por: Ouyang, Jia-Ying, et al.
Publicado: (2023)

Enrichment of progenitor cells by 2‐acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo
por: Castro‐Gil, María Paulette, et al.
Publicado: (2021)

Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
por: Jiang, Nan, et al.
Publicado: (2021)

Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives
por: Girardi, Daniel M., et al.
Publicado: (2023)

Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma
por: Cerrato-Izaguirre, Dennis, et al.
Publicado: (2022)

Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
por: Xue, Zhong, et al.
Publicado: (2023)

Immunotherapy for hepatocellular carcinoma: Current and future
por: Johnston, Michael P, et al.
Publicado: (2019)

Current Imaging Diagnosis of Hepatocellular Carcinoma
por: Chartampilas, Evangelos, et al.
Publicado: (2022)

Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation
por: Huang, Jihan, et al.
Publicado: (2020)

Fundamentos de auditoría /
por: Espino García, Melquiades Gabriel
Publicado: (2014)

Fundamentos de la Ley Sarox /
por: Espino García, Melquiades Gabriel
Publicado: (2017)

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
por: Romualdo, Guilherme Ribeiro, et al.
Publicado: (2021)

Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome
por: Quezada, Julio, et al.
Publicado: (2018)

Pharmacological Mechanisms Underlying the Hepatoprotective Effects of Ecliptae herba on Hepatocellular Carcinoma
por: Pan, Botao, et al.
Publicado: (2021)

In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells
por: Hernandez-Delgadillo, Rene, et al.
Publicado: (2018)

Current staging of hepatocellular carcinoma: imaging implications
por: Bhosale, P, et al.
Publicado: (2006)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015)

GPC-3 in hepatocellular carcinoma: current perspectives
por: Wu, Yongle, et al.
Publicado: (2016)

Current topics in the surgical treatments for hepatocellular carcinoma
por: Ban, Daisuke, et al.
Publicado: (2018)

Current Status of Gene Therapy in Hepatocellular Carcinoma
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019)

Current role of ultrasound in the diagnosis of hepatocellular carcinoma
por: Tanaka, Hironori
Publicado: (2020)

Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
por: Zhong, Cheng, et al.
Publicado: (2021)

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
por: Adeniji, Nia, et al.
Publicado: (2021)

Ruptured Hepatocellular Carcinoma: Current Status of Research
por: Xia, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k4skpumtmg0ffdq08a935fbqnp